Viewing Study NCT01152567


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2025-12-27 @ 8:24 AM
Study NCT ID: NCT01152567
Status: COMPLETED
Last Update Posted: 2011-09-27
First Post: 2010-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module